Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 200.00% vs 0.00% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 59.55% vs -60.94% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 27.34% vs 10.90% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 4.76% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of BioXcel Therapeutics, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 200.00% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -25.00% vs 0.00% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 59.55% vs -60.94% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -14.68% vs 51.12% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 27.34% vs 10.90% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -1.00% vs 49.24% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 4.76% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 10.00% vs 17.65% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024






